![]()
|
|
||||||||
J Biol Chem, Vol. 273, Issue 34, 21988-21997, August 21, 1998
From the The binding of human immunodeficiency virus (HIV)
type 1 particles to CD4+ cells could be blocked
either by antibodies against the V3 loop domain of the viral external
envelope glycoprotein gp120, or by the V3 loop mimicking pseudopeptide
5[K
Identification of V3 Loop-binding Proteins as Potential Receptors
Implicated in the Binding of HIV Particles to CD4+
Cells
,
,
,
,
,
,
,
Unité de Virologie et Immunologie
Cellulaire,
(CH2N)PR]-TASP, which forms a stable complex with a
cell-surface-expressed 95-kDa protein. Here, by using an affinity
matrix containing 5[K
(CH2N)PR]-TASP and cytoplasmic
extracts from human CEM cells, we purified three V3 loop-binding
proteins of 95, 40, and 30 kDa, which after microsequencing were
revealed to be as nucleolin, putative HLA class II-associated protein (PHAP) II, and PHAP I, respectively. The 95-kDa cell-surface protein was also isolated and found to be nucleolin. We show that recombinant preparations of gp120 bind the purified preparations containing the V3 loop-binding proteins with a high affinity, comparable to the binding of gp120 to soluble CD4. Such binding is
inhibited either by 5[K
(CH2N)PR]-TASP or antibodies
against the V3 loop. Moreover, these purified preparations inhibit HIV entry into CD4+ cells as efficiently as soluble CD4. Taken
together, our results suggest that nucleolin, PHAP II, and PHAP I
appear to be functional as potential receptors in the HIV binding
process by virtue of their capacity to interact with the V3 loop of
gp120.
Copyright © 1998 by The American Society for Biochemistry and Molecular Biology, Inc.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
H. Shi, Y. Huang, H. Zhou, X. Song, S. Yuan, Y. Fu, and Y. Luo Nucleolin is a receptor that mediates antiangiogenic and antitumor activity of endostatin Blood, October 15, 2007; 110(8): 2899 - 2906. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. Robinson, J. F. Sinclair, M. J. Smith, and A. D. O'Brien Shiga toxin of enterohemorrhagic Escherichia coli type O157:H7 promotes intestinal colonization PNAS, June 20, 2006; 103(25): 9667 - 9672. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Kim, D. D. Dimitrova, K. M. Carta, A. Saxena, M. Daras, and J. A. Borowiec Novel Checkpoint Response to Genotoxic Stress Mediated by Nucleolin-Replication Protein A Complex Formation Mol. Cell. Biol., March 15, 2005; 25(6): 2463 - 2474. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Mi, S. D. Thomas, X. Xu, L. K. Casson, D. M. Miller, and P. J. Bates Apoptosis in Leukemia Cells Is Accompanied by Alterations in the Levels and Localization of Nucleolin J. Biol. Chem., February 28, 2003; 278(10): 8572 - 8579. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Shibata, T. Muramatsu, M. Hirai, T. Inui, T. Kimura, H. Saito, L. M. McCormick, G. Bu, and K. Kadomatsu Nuclear Targeting by the Growth Factor Midkine Mol. Cell. Biol., October 1, 2002; 22(19): 6788 - 6796. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. A. Said, B. Krust, S. Nisole, J. Svab, J.-P. Briand, and A. G. Hovanessian The Anti-HIV Cytokine Midkine Binds the Cell Surface-expressed Nucleolin as a Low Affinity Receptor J. Biol. Chem., September 27, 2002; 277(40): 37492 - 37502. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Nisole, E. A. Said, C. Mische, M.-C. Prevost, B. Krust, P. Bouvet, A. Bianco, J.-P. Briand, and A. G. Hovanessian The Anti-HIV Pentameric Pseudopeptide HB-19 Binds the C-terminal End of Nucleolin and Prevents Anchorage of Virus Particles in the Plasma Membrane of Target Cells J. Biol. Chem., May 31, 2002; 277(23): 20877 - 20886. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Xu, F. Hamhouyia, S. D. Thomas, T. J. Burke, A. C. Girvan, W. G. McGregor, J. O. Trent, D. M. Miller, and P. J. Bates Inhibition of DNA Replication and Induction of S Phase Cell Cycle Arrest by G-rich Oligonucleotides J. Biol. Chem., November 9, 2001; 276(46): 43221 - 43230. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Krust, R. Vienet, A. Cardona, C. Rougeot, E. Jacotot, C. Callebaut, G. Guichard, J. P. Briand, J. M. Grognet, A. G. Hovanessian, et al. The anti-HIV pentameric pseudopeptide HB-19 is preferentially taken up in vivo by lymphoid organs where it forms a complex with nucleolin PNAS, October 31, 2001; (2001) 221467298. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Bacharach, J. Gonsky, K. Alin, M. Orlova, and S. P. Goff The Carboxy-Terminal Fragment of Nucleolin Interacts with the Nucleocapsid Domain of Retroviral Gag Proteins and Inhibits Virion Assembly J. Virol., December 1, 2000; 74(23): 11027 - 11039. [Abstract] [Full Text] |
||||
![]() |
M. Srivastava and H. B. Pollard Molecular dissection of nucleolin's role in growth and cell proliferation: new insights FASEB J, November 1, 1999; 13(14): 1911 - 1922. [Abstract] [Full Text] |
||||
![]() |
S. Nisole, B. Krust, C. Callebaut, G. Guichard, S. Muller, J.-P. Briand, and A. G. Hovanessian The Anti-HIV Pseudopeptide HB-19 Forms a Complex with the Cell-surface-expressed Nucleolin Independent of Heparan Sulfate Proteoglycans J. Biol. Chem., September 24, 1999; 274(39): 27875 - 27884. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. J. Bates, J. B. Kahlon, S. D. Thomas, J. O. Trent, and D. M. Miller Antiproliferative Activity of G-rich Oligonucleotides Correlates with Protein Binding J. Biol. Chem., September 10, 1999; 274(37): 26369 - 26377. [Abstract] [Full Text] [PDF] |
||||
![]() |
H Ginisty, H Sicard, B Roger, and P Bouvet Structure and functions of nucleolin J. Cell Sci., January 3, 1999; 112(6): 761 - 772. [Abstract] [PDF] |
||||
![]() |
J. F. Sinclair and A. D. O'Brien Cell Surface-localized Nucleolin Is a Eukaryotic Receptor for the Adhesin Intimin-gamma of Enterohemorrhagic Escherichia coli O157:H7 J. Biol. Chem., January 18, 2002; 277(4): 2876 - 2885. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Krust, R. Vienet, A. Cardona, C. Rougeot, E. Jacotot, C. Callebaut, G. Guichard, J. P. Briand, J. M. Grognet, A. G. Hovanessian, et al. The anti-HIV pentameric pseudopeptide HB-19 is preferentially taken up in vivo by lymphoid organs where it forms a complex with nucleolin PNAS, November 20, 2001; 98(24): 14090 - 14095. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |